首页|期刊导航|中华医学杂志(英文版)|Primary regional disparities in clinical characteristics,treatments,and outcomes of a typically designed study of valvular heart disease at 46 tertiary hospitals in China:Insights from the China-VHD Study
Primary regional disparities in clinical characteristics,treatments,and outcomes of a typically designed study of valvular heart disease at 46 tertiary hospitals in China:Insights from the China-VHD Study
Xiangming Hu Zhenya Duan Bincheng Wang Bin Zhang Junxing Lv Shuai Guo Yanyan Zhao Runlin Gao Haiyan Xu Yongjian Wu China-VHD Study Collaborators Yunqing Ye Zhe Li Qingrong Liu Zhenyan Zhao Zheng Zhou Weiwei Wang Zikai Yu Haitong Zhang
中华医学杂志(英文版)2025,Vol.138Issue(8):937-946,10.
中华医学杂志(英文版)2025,Vol.138Issue(8):937-946,10.DOI:10.1097/CM9.0000000000003570
Primary regional disparities in clinical characteristics,treatments,and outcomes of a typically designed study of valvular heart disease at 46 tertiary hospitals in China:Insights from the China-VHD Study
Primary regional disparities in clinical characteristics,treatments,and outcomes of a typically designed study of valvular heart disease at 46 tertiary hospitals in China:Insights from the China-VHD Study
摘要
关键词
Valvular heart disease/China/Regional difference/Etiology/Treatment/OutcomeKey words
Valvular heart disease/China/Regional difference/Etiology/Treatment/Outcome引用本文复制引用
Xiangming Hu,Zhenya Duan,Bincheng Wang,Bin Zhang,Junxing Lv,Shuai Guo,Yanyan Zhao,Runlin Gao,Haiyan Xu,Yongjian Wu,China-VHD Study Collaborators,Yunqing Ye,Zhe Li,Qingrong Liu,Zhenyan Zhao,Zheng Zhou,Weiwei Wang,Zikai Yu,Haitong Zhang..Primary regional disparities in clinical characteristics,treatments,and outcomes of a typically designed study of valvular heart disease at 46 tertiary hospitals in China:Insights from the China-VHD Study[J].中华医学杂志(英文版),2025,138(8):937-946,10.基金项目
This work was supported by the Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences(No.2017-12M-3-002),the Clinical and Translational Medicine Research Project,Chinese Academy of Medical Sciences(No.2021-12M-C&T-B-029),the Beijing Natu-ral Science Foundation(No.7244395),and the National Key R&D Program of China(No.2020YFC2008100). (No.2017-12M-3-002)